EUVIMEDEUVIMED entdecken
Crossref

PAK2 Signaling in Ovarian Cancer: Molecular Mechanisms and Clinical Implications: Narrative Review

Anas Basim Al-Hadethi, Mohammed Ibrahim Anwer, Noori Taha Alkhafaji

IFR Journal of Medicine and Surgery · 04.01.2026 · 3 (1) · 30-39

DOI: 10.70146/msv03i01.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IFR Journal of Medicine and Surgery, erschienen am 04.01.2026. Verfasst von Anas Basim Al-Hadethi und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PAK2 is a mechanochemical node that integrates Rac1/Cdc42, β1-integrin–FAK/SRC and receptor tyrosine kinase inputs to license ERK and AKT cascades, remodel focal adhesions, and sustain YAP–TAZ activity. In ovarian cancer, these programs support anchorage independence, survival in ascites, mesothelial clearance, and peritoneal dissemination. Context-dependent proteolysis by caspase-3 yields the ~34-kDa p34 fragment, adding an apoptosis–survival switch that may influence treatment responses. Across histotypes, high PAK2 expression and activity associate with aggressive behavior, suggesting prognostic utility; predictive value remains unproven. Therapeutically, direct PAK blockade and rational combinations that co-target PI3K–AKT–mTOR, MEK/ERK (notably in low-grade serous disease) and the β1-integrin–FAK/SRC hub are mechanistically justified; pairing with DNA damage response agents may be explored in homologous-recombination–deficient settings. We synthesize mechanistic and clinical data to position PAK2 as a tractable driver of motility, survival, and metabolic adaptability in the ovarian tumor ecosystem. Prospective, biomarker-anchored studies using dissemination-relevant endpoints are required to test risk-enrichment strategies and define whether PAK2 can serve as a therapeutic predictor beyond its emerging prognostic role.

Zitieren

APA

Al-Hadethi, A. B., Anwer, M. I., & Alkhafaji, N. T. (2026). PAK2 Signaling in Ovarian Cancer: Molecular Mechanisms and Clinical Implications: Narrative Review. IFR Journal of Medicine and Surgery, 3(1), 30-39. https://doi.org/10.70146/msv03i01.003

Vancouver

Al-Hadethi AB, Anwer MI, Alkhafaji NT. PAK2 Signaling in Ovarian Cancer: Molecular Mechanisms and Clinical Implications: Narrative Review. IFR Journal of Medicine and Surgery. 2026;3(1):30-39. doi:10.70146/msv03i01.003

BibTeX
@article{AlHadethi2026,
  author = {Al-Hadethi, Anas Basim and Anwer, Mohammed Ibrahim and Alkhafaji, Noori Taha},
  title = {PAK2 Signaling in Ovarian Cancer: Molecular Mechanisms and Clinical Implications: Narrative Review},
  journal = {IFR Journal of Medicine and Surgery},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {30--39},
  doi = {10.70146/msv03i01.003}
}
Kostenlos starten →